Physician profile
Meet Patel
NPI 1417730763
$1,196.86
in general payments reported to CMS, 2019-2025
17 companies · $459 in 2025
The $459 reported for 2025 was more than what a typical Family provider received nationally (typical 2025 total: $167).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2023: $101 · 2024: $637 · 2025: $459.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $1,197.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $1,196.86 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Astrazeneca Pharmaceuticals LP | $363.65 | 2023-2025 | Airsupra, Farxiga, Breztri |
| Novo Nordisk INC | $200.33 | 2023-2025 | Wegovy, Ozempic, Rybelsus |
| Pfizer INC. | $130.07 | 2024-2025 | |
| Abbvie INC. | $68.43 | 2024-2025 | |
| Amgen INC. | $62.67 | 2024-2025 | Repatha, Otezla, Otezla |
| Boehringer Ingelheim Pharmaceuticals, INC. | $59.70 | 2025 | Jardiance |
| Glaxosmithkline, LLC. | $50.50 | 2025 | Trelegy Ellipta |
| Dexcom, INC. | $47.44 | 2024-2025 | Dexcom G6 Transmitter |
| Boston Scientific Corporation | $42.95 | 2023-2024 | Watchman Flx, Watchman Access System |
| Merck Sharp & Dohme LLC | $34.16 | 2024 | Capvaxive |
| Radius Health, INC. | $34.09 | 2025 | Tymlos |
| Salix Pharmaceuticals, A Division of Bausch Health US, LLC | $31.13 | 2023 | Xifaxan |
| Astellas Pharma US INC | $17.22 | 2024 | Veozah |
| Harmony Biosciences LLC | $16.13 | 2025 | |
| Verona Pharma, INC. | $14.86 | 2025 | Ohtuvayre |
Show all 17 companies
| Company | General payments | Years | Top products |
|---|---|---|---|
| Lilly USA, LLC | $13.53 | 2024 | Zepbound |
| Cequr Corporation | $10.00 | 2025 | Cequr Simplicity |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Meet Patel listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.